IRVINE, Calif., March 20, 2026 (GLOBE NEWSWIRE)-- WallabyPhenox today announced the successful treatment of the first U.S. patient in the p48 and p64 MW HPC in Aneurysm Occlusion (PIANO) IDE trial, ...
IRVINE, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- WallabyPhenox today announced the successful treatment of the first U.S. patient in the p 48 and p64 MW HPC i n An eurysm O cclusion (PIANO) IDE ...